Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion type Assertion NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_head.
- NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion description "[We also found that the 3435TT genotype of MDR1 was associated with a lower risk of non-cardiac cancer (OR = 0.42; 95% CI = 0.23-0.79), middle-third cancer (OR = 0.36; 95% CI = 0.17-0.77), advanced cancer (OR = 0.31; 95% CI = 0.13-0.73), venous invasion (OR = 0.30; 95% CI = 0.10-0.91), and lymph node metastasis (OR = 0.28; 95% CI = 0.13-0.65).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_provenance.
- NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion evidence source_evidence_literature NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_provenance.
- NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion SIO_000772 17608636 NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_provenance.
- NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion wasDerivedFrom befree-2016 NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_provenance.
- NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_assertion wasGeneratedBy ECO_0000203 NP618288.RA60YhWaSrAbNzz-sGDwR6IKIJUr0drDqene8nq6fPI58130_provenance.